Where can I buy the drug Platinib?

Pralsetinib (Pralsetinib), the original drug, has been launched in China, but it has not yet passed the relevant policies of being included in medical insurance. This drug may be sold in domestic hospitals or pharmacies, but patients can purchase the drug with a prescription issued by a doctor. There are European and American versions of the original Platinib drug sold overseas; generic versions of Platinib are also produced and sold. Its pharmaceutical ingredients are basically the same as those of the original drug sold domestically and abroad. Generic drugs need to be purchased through formal channels. For more information on overseas drug prices and drug information, please consult a medical consultant.

Platinib is an oral, potent and highly selective investigational drug that targets oncogenicRET mutations. It has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA) and approved by the State Food and Drug Administration in China. As a precision treatment drug for metastatic non-small cell lung cancer and thyroid cancer with positive RET fusion gene mutations, it is sold under the name Platinib capsules after its launch, and its trade name is Gavreto/Pujihua.

The main effect of platinib is to inhibit the growth and spread of cancer cells by targeting RET gene fusion tumor cells. This drug has shown significant therapeutic efficacy in the treatment of RET fusion-positive non-small cell lung cancer that has progressed after platinum-containing chemotherapy, as well as in patients with RET mutation-positive medullary thyroid cancer who require systemic therapy and have no alternative treatment options. In addition, Platinib has also shown positive effects on improving patient symptoms and prolonging survival. However, the specific therapeutic effect may vary depending on individual differences among patients, so when using platinib for treatment, individualized dosage adjustments need to be made based on the patient's specific conditions.